NEU.AX - Neuren Pharmaceuticals Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Operating expenses
Research development
9,858
9,858
6,101
5,136
12,441
Selling general and administrative
1,713
1,713
2,074
1,568
2,726
Total operating expenses
11,571
11,571
8,175
6,704
15,167
Operating income or loss
-11,571
-11,571
-8,175
-6,704
-15,167
Total other income/expenses net
366
366
11,030
9,945
1,121
Income before tax
-10,816
-10,816
3,073
3,288
-13,858
Income tax expense
0
0
0
0
-1,844
Income from continuing operations
-10,816
-10,816
3,073
3,288
-12,014
Net income
-10,816
-10,816
3,073
3,288
-12,014
Net income available to common shareholders
-10,816
-10,816
3,073
3,288
-12,014
Basic EPS
-
-
0.03
-0.02
-0.14
Diluted EPS
-
-
0.03
-0.02
-0.14
Basic average shares
-
-
99,039
96,461
89,175
Diluted average shares
-
-
99,039
96,461
89,175
EBITDA
-
-11,571
-8,175
-6,704
-15,167